香港六合彩开奖结果

Vol. 21 No. 2 (2022)
Original Articles

Seroprevalence of hepatitis A, B and C infections among patients attending health care facilities in two riverine communities in Akwa Ibom State, Nigeria

PDF
  • Dora I. Udoh,
  • Baritudor T. Siedoma,
  • Aniekan-Augusta O. Eyo
DOI:

Published 2023-01-03

How to Cite

1.
I. Udoh D, T. Siedoma B, O. Eyo A-A. Seroprevalence of hepatitis A, B and C infections among patients attending health care facilities in two riverine communities in Akwa Ibom State, Nigeria. BJHBS [Internet]. 2023 Jan. 3 [cited 2024 Oct. 12];21(2):111-20. Available from: /bjhbs/article/view/11

Copyright (c) 2022 香港六合彩开奖结果

This work is licensed under a .

Crossref
Scopus

Abstract

Introduction: Hepatitis infections are endemic in many聽countries. The serological hallmark for these infections is聽the presence of antibodies and antigens in the blood of the聽infected persons. These serological markers give an idea on the聽seropositivity of specific hepatitis. Objectives: This research聽was designed to investigate the seroprevalence of hepatitis A聽(HAV), B (HBV) and C (HCV) infections among patients attending聽health care facilities in two riverine communities in Akwa聽Ibom State, Nigeria. Methods: A cross sectional-descriptive study聽was conducted in two riverine communities, namely: Ikot Abasi聽and Oron, as well as one upland community, Uyo, as a control.聽Ethical approval and consents were obtained from the State聽Ministry of Health and volunteers. Three hundred (300) blood聽samples, 100 samples from each study area were collected and聽tested for the presence of HAV, HBV, and HCV antibodies and聽antigens using hepatitis rapid immunoassay and antibodies kits聽(Acon Diagnostics, USA), respectively. Structured questionnaires聽were used to obtain socio-demographic information from participants.聽Results: The prevalence rates of HAV, HBV, and HCV聽infections were: 14%, 10% and 6% in Ikot Abasi; 20%, 14% and聽8% in Oron; while Uyo recorded 2%, 12% and 6%, respectively.聽The prevalence of HAV infection at the riverine communities聽was significantly higher than in the control (p=0.016). Children聽鈮� 10 years showed a higher prevalence of HAV. The prevalence聽of HBV and HCV infections in the riverine communities did聽not differ from the control (p=0.011). Prevalence based on socio-demographic parameters differed (p<0.05) in some studyareas. Conclusion: Predisposing factors for the transmission of聽hepatitis A infection, such as indiscriminate sewage disposal,聽lack of awareness and sensitization campaign abound inriverine communities. These factors are not responsible for聽transmission of HBV and HCV infections in both the riverineand non-riverine communities. Therefore, proper hygiene,good sexual conduct, awareness and vaccination campaign聽are encouraged in the study areas.

PDF

Metrics

Metrics Loading ...

References

  1. Ahmedin J, Taylor M, Ram CT. A new section in cancer offering timely and targeted information, Can J Clin, 2004;54: 23-25.
  2. WHO Hepatitis A fact sheet N0328. World Health Organization. July 2013, archived 20th February, 2014.
  3. Olawale G. 22.6 million Nigerians suffering from Hepatitis 鈥� FG, Vanguard (2016). Available from: . Access on: Jan, 22nd, 2022.
  4. Amarapurkar D. Natural history of hepatitis C virus infection. J Gastro & Hepatol, 2000 May;15 Suppl:E105鈥�10.
  5. Hall GF. Hepatitis A, B, C, D, E, G: An Update, Ethn & Dis, 2007;17(2):40-45.
  6. Matheny SC, Kingery JE. Hepatitis A. Am Fam Physician. 2012; 86(11):1027-3.
  7. Cheesbrough M. District laboratory practice in tropical countries (part 2) Cambridge University press; 2000. p 250 鈥�253.
  8. Wheeler C, Vogt TM, Armstrong GL, et al. An outbreak of hepatitis A associated with green onions. N Engl J Med, 2005; 353(9):890-7.
  9. Musa BM, Bussel S, Borodo MM, et al. Prevalence of hepatitis B virus infection in Nigeria, 2000-2003: a systemic review and meta-analysis. Nig j of clin pract. 2015;18 (issue 2):163-72.
  10. Lesi OA, Kehinde MO, Omilabu SA. Prevalence of the HBeAg in Nigeria patients with chronic liver disease. Nig Hop Med. 2004;1-4.
  11. Ndubula DA, Ojo OS, Adetiloye VA, et al. Chronic hepatitis in Nigerian university patients: A study of 70 biosy-proven casas. West Afr. J med. 2005;24:107-11.
  12. Ola SO, Odaibo GN. Alfa-Feto protein HCB and HBV infections in Nigerian patients with primary hepatocellular carcinoma. Nig Med Pract. 2007;51:33-35.
  13. Malu AO, Borodo MM, Ndububa DA, et al., Hepatitis B and C treatment guidelines for Nigeria. Nig J Gastro Hepatol. 2015;7(2):63-75.
  14. Agbede OO, Iseniyi, JO, Kolawole, et al. Rik factors and seroprevalence of hepatitis B surface antigenaemia in mothers and their pre-school age children in Ilorin. Nig Therapy. 2007;4(1) 67-72.
  15. Weinbaum CM, William I, Mast EE, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep. 2008;57(RR-8):1-20.
  16. Obienu O, Nwokediuko S, Malu A, et al. Risk factors for hepatitis C virus transmission obscure in Nigerian patients. Gastro Res Prac. 2011;v2011 article ID 939673. https//doi org/10.1155/2011/939673.
  17. Onyekwere CA, Hammed I. Hepatitis B and C virus; prevalence and association with demographics: Report of population screening in Nigeria. Trop. Doc. 2015;45(4):231-5.
  18. O鈥橪eary JG, Davis GL. Hepatiutis C. In: M Feldman, et al.7theds, Sleisenger and Fordtran鈥檚 Gastrointestinal and Liver Diseases, 9th ed., Philadelphia: Saunder Elsevier. 2008. vol. 2, p. 1313-1335.
  19. Bhattacharya P, Chandra PK, Data S, et al. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005. Exploratory screening reveals high frequency of occult HBV infection. W J gastroenterol. 2007;13(27):3730 -3.
  20. Afsar I, Gungor S, Sener AG, et al. The prevalence of HBV, HCV, and HIV infections among blood donors in Izmir, Turkey. Ind J Med. Micro. 2010;26(3):283-9.
  21. De Paula ME. Arudda CL, Vitral AMC et al. (2001). Seroprevalence of Viral Hepatitis in Riverine Communities from the Western Region of the Brazilian Amazon Basin. Mem. Inst. Oswaldo Cruz. 2001;96(8):1123鈥�28.
  22. Steffen R. 鈥淐hanging travel-related global epidemiology of hepatitis A鈥�. Am. J. Med. 2005;118Suppl 10A):46S 49S. doi:10.1016/j.amjmed.2005.07.016. PMID 16271541
  23. Carroll K. 鈥淗epatitis Viruses鈥�. Medical Microbiology. (2015) 鈥淐hapter 35: New York: McGraw-Hill. ISBN 9780071824989. Available at: . Access on: Jan, 13th, 2022.
  24. Aggarwal R, Goel A. 鈥淗epatitis A鈥�. Curr Opin in Infec Dis. 2015.28(5):488鈥�496. doi:10.1097/qco.0000000000000188. PMID 26203853. S2CID 22340290.
  25. Alan MM, Zaidi SZ, Malik SA, et al., Molecular epidemiology of Hepatitis B virus genotypes in Pakistan. BMC Infec Dis. 2007;7:115. doi10.1186/1471-2334-115.
  26. Olokoba AB, Salawa FK, Danburan A, et al. Viral hepatitis in voluntary blood donors in Yola, Nigeria. Eur J Sci Res. 2009;31(3):329-34.
  27. Pennap GR, Yakubu A, Oyige O, et al. Prevalence of hepatitis B and C virus infections among people of a local community in Keffi, Nigeria. Afr J Micro Res. 2010;4(4):274-8.
  28. Odusanya OO, Alufohai FE, Meurice FP, et al., Prevalence of hepatitis B surface antigen in vaccinated children and controls in rural Nigeria. Inter J Infect Dis. 2005;9(3):139-43.
  29. Okonko I, Soleye FA, Alli JA, et al. Seropravalence of Hbsag antigenaemia among patients in Abeokuta ,South Western Nigeria. G J Med Res. 2010;10(2):40-9.
  30. Bwoyi J, Braka F, Makanbi I. Hepatitis B infection is highly endemic in Uganda: Finding from a national serosurvey. Afr Health Sc. 2009;9:98- 108.
  31. Okonkwo UC, Okpara H, Otu A, et al. Prevalence of hepatitis B, hepatitis C and human immunodeficiency viruses, evaluation of risk factors for transmission: Report of a population screening in Nigeria. S. Afr. Med. J. 2017;107(4):346-51. doi:10.7196/SAMJ.2017.v10714.12198.
  32. Balogun TM, Emmanuel S, Ojerinde EF. HIV, Hepatitis B and C viruses鈥� coinfection among patients in a Nigeria tertiary hospital. Pan Afr, Med J. 2012;12:100.
  33. Sirisena ND, Njoku MO, Ioko JA, et al., Carriage rates of Hbsag in an urban community in Jos, Plateau, Nigeria. Nig postgrad Med J. 2002;9:7-10.
  34. Ezegbudo CN, Agbonlabor DE, Nwobu CO, et al. The seropravalence of the hepatitis B surface antigen and human immunodeficiency virus among pregnant women in Anambra State, Nigeria. Shiraz E med J. 2004;5(2):21-5.
  35. Centre for Disease Control and Prevention. Hepatitis B Virus (HBV) .In infections during pregnancy. Available from: . Access on: Jan, 15th, 2022.
  36. Belo AC. Prevalence of hepatitis B virus markers in surgeons in Lagos, Nigeria. East Afr Med J. 2000;77:283-5.
  37. Bada AS, Olatunji PO, Adewuji JO, et al. Hepatitis B surface antigenaemia in Ilorin, Kwara State Nigeria. Cent Afr J Med. 1996; 42:139-41.
  38. Lewis J, Enfield K, Sifri C. Hepatitis B in healthcare workers: transmission events and guidelines for management. W J Hepatol. 2015;25;7(3):488-97. doi:10.4254/wjh.v7.i3.488.